Elpiscience and Astellas collaborate for novel bispecific macrophage engager
Elpiscience will receive up to US $37 million, including the upfront payment and license option fees
Elpiscience will receive up to US $37 million, including the upfront payment and license option fees
Lonza supports development and manufacturing of ABL Bio’s bispecific antibody candidate with a complete and integrated end-to-end solution
The product is backed by required scientific proof and comparative bioequivalence studies
Recognition illustrates Takeda’s patient-centricity throughout its manufacturing and supply processes
The expansion reiterates BASF’s continued commitment to Asia Pacific and specifically to customers in the medical glove industry
Zerion´s innovative Dispersome technology builds on a new concept of increasing drug solubility by using natural protein-based excipients to formulate APIs into amorphous solid dispersions (ASDs) by spray drying
Immatics to receive upfront payment of US $ 150 million and additional milestone payments of up to US $ 770 million plus tiered double-digit royalties on net product sales
High-resolution image-based ART workflow software uses artificial intelligence to provide objective embryo grading, to assist embryologists during embryo selection
Hepatitis B infects over 40 million people in India
Subscribe To Our Newsletter & Stay Updated